Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS).
about
Pathology of rituximab-induced Kaposi sarcoma flareIntravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia.Low-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patientsLong-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.Confusion in the Study of Immune Reconstitution Inflammatory Syndrome.KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseEpidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.Update on Kaposi's Sarcoma: A Gammaherpesvirus- induced Malignancy.Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.Oral candidiasis, HIV, and saliva glucocorticoidsExpression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma.AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation.Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.Evidence for multiclonality in multicentric Kaposi's sarcoma.Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma.Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infectionDifferences in androgens of HIV positive patients with and without Kaposi sarcoma.Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.Management of the immune reconstitution inflammatory syndrome.Multicentric Castleman's disease: a challenging diagnosis.A case of exogenous corticosteroid-induced Kaposi's sarcoma that developed after a cure of endogenous hypercortisolism.Effect of interferon alpha on high serum androgen concentrations in HIV positive men with Kaposi's sarcomaMinimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines.Pulmonary Kaposi sarcoma and disseminated Mycobacterium genavense infection in an HIV-infected patient.Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia.The impact of HIV on the prevalence of asthma in Uganda: a general population survey
P2860
Q33354623-93EA16E1-7705-45E1-862D-10777233214AQ33375052-E39BB08F-1F3E-43B9-8352-08E0BD82CA09Q33760023-FDDBB6B0-7244-4773-AE1A-429F7D1A6D4BQ33817882-8A8E1F9A-A88D-488E-8659-2BD2D3378DBBQ33920429-B6948DFB-ECC3-4EB3-9484-FF82E41D7715Q34417383-075A2D57-D398-4C58-9A57-8E02925E09E5Q34633782-0612A175-23ED-4F4E-B8F9-1E5E0BA11946Q34636851-105CC2E2-4379-4880-BAFB-E165D5D13908Q34637897-C040177E-C916-44A3-86B3-F052880C11DFQ35044092-15366641-E472-42B2-96E8-9EA286A9B47EQ35567001-FA282FC2-307E-4539-B05C-1901B269CF99Q35773574-E16BF250-D5EA-4050-8D3B-9638C3E9F576Q35773933-25AEB56E-1232-4F21-AC3A-AA100357334AQ35794851-6204F894-4870-43AF-9B87-329BFDE49803Q35795414-E5C5C0DC-4ECA-4369-806A-1D76A229DEFDQ35891202-6ED8F8C0-D4E4-48FA-9CAD-2D7B42B793E7Q36173459-31C53DE6-7C29-4AC1-8011-3F5BF68A7246Q36506932-0B635C84-1836-43D0-A9E0-7E988FEFA044Q36569469-93318C9C-AE38-4F9E-9A9C-5464AE6235DAQ36692638-4D4ADF8C-9803-4579-A231-385C1CBF4075Q37262871-4BE719AE-3A78-4E64-A0FA-B843A7A4F58BQ37280724-78170500-08F0-4B51-AC71-AA6C88C9BD47Q38023242-1D76A6E7-26D1-45A1-9183-BFC9D147A4CFQ38091671-04CCBB2F-59F8-4CD5-BD0F-BC9D1706AFA9Q38423241-1B0B6C20-8646-4AB2-ABD8-2BA4B52EA6A0Q39566440-A7C7F345-DA33-4A57-868B-681E7E4DB0C7Q40756773-EE4FDE07-99AB-4CE1-8F28-9B0F366EF510Q40959619-7C4C9194-DBEC-4AB6-B9F3-05B7988EC7F4Q46176384-5CAD8A7E-869C-4BD9-A189-F717036E70F8Q56909304-A390C4A3-D04F-4C57-A9F9-902537E454ED
P2860
Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS).
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Clinical effect of glucocortic ...... unodeficiency syndrome (AIDS).
@en
Clinical effect of glucocortic ...... ired immunodeficiency syndrome
@nl
type
label
Clinical effect of glucocortic ...... unodeficiency syndrome (AIDS).
@en
Clinical effect of glucocortic ...... ired immunodeficiency syndrome
@nl
prefLabel
Clinical effect of glucocortic ...... unodeficiency syndrome (AIDS).
@en
Clinical effect of glucocortic ...... ired immunodeficiency syndrome
@nl
P2093
P1476
Clinical effect of glucocortic ...... unodeficiency syndrome (AIDS).
@en
P2093
Bernstein-Singer M
Loureiro C
P304
P356
10.7326/0003-4819-110-11-937
P407
P577
1989-06-01T00:00:00Z